Get short, timely messages from Actelion.

Twitter is a rich source of instantly updated information. It's easy to stay updated on an incredibly wide variety of topics. Join today and follow @actelion_com.

Get updates via SMS by texting follow actelion_com to 40404 in the United States
Codes for other countries

Country	Code	For customers of
Two-way (sending and receiving) short codes:
Australia	0198089488 Telstra
Canada	21212 (any)
United Kingdom	86444 Vodafone, Orange, 3, O2
Indonesia	89887 AXIS, 3, Telkomsel
Ireland	51210 O2
India	53000 Bharti Airtel, Videocon
Jordan	90903 Zain
New Zealand	8987 Vodafone, Telecom NZ
United States	40404 (any)

actelion_com

Actelion presents its strategy for value creation: bit.ly/LB5dIY 10:18 PM May 7th via twitterfeed
Actelion's Annual General Meeting of Shareholders held in Basel, Switzerland: bit.ly/Ken99b 5:37 AM May 4th via twitterfeed
Actelion to host Company Update Conference Call / Audiocast: bit.ly/K9xJls 8:41 AM May 2nd via twitterfeed
Actelion to host Conference Call / Audiocast on SERAPHIN Study Results: bit.ly/IIddTh 1:01 AM Apr 30th via twitterfeed
Actelion's macitentan meets primary endpoint in pivotal Phase III SERAPHIN outcome study in patients with pulmon... bit.ly/IIddTf 1:01 AM Apr 30th via twitterfeed
Investor Conference Call on macitentan results in SERAPHIN study: April 30, 14.00 Basel/ 13.00 UK / 8.00 US. actelion.com/en/investors/e…? 11:45 PM Apr 29th via web
Guy Braunstein: "Our thanks go to the investigators and their staff, who participated in this compelling study." actelion.com/en/journalists…? 10:56 PM Apr 29th via web
Jean-Paul Clozel: "I am extremely pleased with the outstanding macitentan results in SERAPHIN." actelion.com/en/journalists…? twitter.com/actelion_com/s… 10:34 PM Apr 29th via web
Macitentan meets primary endpoint in Phase III outcome study. actelion.com/en/index.page 10:17 PM Apr 29th via web
Actelion announces first quarter 2012 financial results: bit.ly/ITF6vw 10:04 PM Apr 18th via twitterfeed
Actelion to discuss first quarter 2012 financial results: bit.ly/IEYX1A 9:36 AM Apr 12th via twitterfeed
Global Reach. Prepared for the Future. Background story in Actelion’s Annual Report 2011. annualreport2011.actelion.com/en/ar2011/back… 2:01 AM Apr 12th via web
The Actelion Annual Report is available online. In English and in German. actelion.com/en/our-company…? 5:44 AM Apr 10th via web
Japan's Ministry of Health, Labour and Welfare grants approval for Actelion's miglustat for the treatment of Nie... bit.ly/HNx2rl 1:06 AM Apr 2nd via twitterfeed
Actelion provides update on CRTH2 program: bit.ly/HNx0j0 1:06 AM Apr 2nd via twitterfeed
“Get involved and discover new territories…” M. Clozel, CSO, endorses the international Biology Olympiad in Bern 2013. ibo2013.org 12:38 AM Mar 30th via web
BioFocus Register now for BioFocus/Actelion high content screening #HCS meeting. 1 day, 9 speakers from across industry, #li bit.ly/wauFEz 2:09 AM Mar 21st via web Retweeted by actelion_com and 2 others
Actelion at tunBasel, an interactive world full of discovery and experiments for kids and young adults: April 13-22. facebook.com/actelion 3:08 AM Mar 19th via web
juanfuertesguil @actelion_com World Pulmonary Hypertension Day, today starts the countdown to May 5 diamundial.hipertensionpulmonar.es/english/ #WPHD 10:22 AM Mar 15th via web Retweeted by actelion_com and 1 other
workingdesign Cool #workspace! Actelion Pharmaceuticals on the @Behance Network: bit.ly/zmFb6z 5:50 PM Mar 7th via Tweet Button Retweeted by actelion_com and 2 others

Name Actelion
Location Allschwil/Basel, Switzerland
Web http://www.acteli...
Bio Actelion is a biopharmaceutical company focusing on the discovery, development and commercialization of innovative treatments to serve high unmet medical needs.